Brief: Adage Capital Partners Reports 9.35% Passive Stake In TScan Therapeutics
12/06/2023 23:32
June 12 (Reuters) - TScan Therapeutics Inc TCRX.O :
* ADAGE CAPITAL PARTNERS, L.P. REPORTS 9.35% PASSIVE STAKE
IN
TSCAN THERAPEUTICS, INC. AS OF MAY 31, 2023 - SEC FILING
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing